Trial site
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
Québec, Quebec G1V 4G5, CanadaNot linked to an institution yet
- 15running trials
- 3closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 24 trials
- Status
- Active, not recruiting7 trials
- Recruiting5 trials
- Not yet recruiting3 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim6 trials
- Medtronic Cardiac Ablation Solutions2 trials
- AGIR à Dom1 trial
- Alethia Biotherapeutics1 trial
- AskBio Inc1 trial
- and 7 more
Running trials
Not yet recruiting
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
NCT07915219· Phase 3· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Not yet recruiting
Physical Activity for Depressive Symptoms in Adults With Obesity: A Randomized Controlled Feasibility Trial
NCT07836582· Universite du Quebec en Outaouais· Source
Contact: Sylvain Iceta, Phd
Recruiting
Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial
NCT07524335· Phase 3· Montreal Heart Institute· Source
Contact: Roubie Dib, MD
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892· Phase 3· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370· Phase 3· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Recruiting
PULSED AF Post-Approval Study
NCT06578104· Medtronic Cardiac Ablation Solutions· Source
Contact: Karine Roy, MD
Active, not recruiting
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· Phase 3· Boehringer Ingelheim· Source
Active, not recruiting
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
NCT05598333· Phase 2· AskBio Inc· Source
Recruiting
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713· Phase 3· University of Manitoba· Source
Contact: Francois Lallouche, MD
Active, not recruiting
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
NCT05846230· Phase 2· Boehringer Ingelheim· Source
Active, not recruiting
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755· Medtronic Cardiovascular· Source
Active, not recruiting
STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation
NCT04428944· McGill University Health Centre/Research Institute of the McGill University Health Centre· Source
Active, not recruiting
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NCT03735667· Boston Scientific Corporation· Source
Recruiting
Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension
NCT02057783· AGIR à Dom· Source
Contact: Simon Gakwaya
Active, not recruiting
PERIGON Pivotal Trial
NCT02088554· Medtronic Cardiac Surgery· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error